MetLife (MET) is a publicly traded Financial Services sector company. As of May 20, 2026, MET trades at $82.40 with a market cap of $52.38B and a P/E ratio of 15.88. MET moved +1.77% today. Year to date, MET is +0.90%; over the trailing twelve months it is +2.71%. Its 52-week range spans $65.21 to $89.05. Analyst consensus is strong buy with an average price target of $93.20. Rallies surfaces MET's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MetLife Commits $170M to Revamp Water Tower Place, Eyes Medical Office Conversion: MetLife's real estate arm is investing $170 million to reposition Chicago's Water Tower Place, four years after seizing the distressed property with over $300 million of debt. The plan includes exploring conversion of upper floors into medical office space and has restored retail occupancy to 70 percent.
| Metric | Value |
|---|---|
| Price | $82.40 |
| Market Cap | $52.38B |
| P/E Ratio | 15.88 |
| EPS | $5.20 |
| Dividend Yield | 0.59% |
| 52-Week High | $89.05 |
| 52-Week Low | $65.21 |
| Volume | 2.09M |
| Avg Volume | 0 |
| Revenue (TTM) | $77.59B |
| Net Income | $3.62B |
| Gross Margin | 0.00% |
11 analysts cover MET: 0 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $93.20.